OBSOLETE: Osteoporosis-macrocephaly-blindness-joint hyperlaxity syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2787
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Osteoporosis-macrocephaly-blindness-joint hyperlaxity syndrome is an extremely rare condition that has been described in medical literature but is now classified as 'obsolete' in disease databases, meaning it may have been reclassified, merged with another condition, or its original description may no longer be considered a distinct syndrome. The condition was originally described as involving a combination of osteoporosis (weakened, fragile bones), macrocephaly (an unusually large head), blindness or severe vision loss, and joint hyperlaxity (overly flexible or loose joints). These features together suggested a connective tissue or skeletal disorder affecting multiple body systems. Because this entry is obsolete, patients who were previously given this diagnosis may now fall under a different, updated diagnostic category. If you or a family member has been told you have this condition, it is important to work with a clinical geneticist to determine whether a more current diagnosis applies. Modern genetic testing may help clarify the underlying cause and guide treatment. Treatment for the individual symptoms — such as bone-strengthening medications for osteoporosis, vision support, and physical therapy for joint problems — may still be relevant regardless of the specific diagnostic label.

Also known as:

Key symptoms:

Fragile or weak bones that break easily (osteoporosis)Unusually large head size (macrocephaly)Blindness or severe vision lossOverly flexible or loose jointsBone pain or frequent fracturesDifficulty with mobility or balance

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Osteoporosis-macrocephaly-blindness-joint hyperlaxity syndrome.

View clinical trials →

No actively recruiting trials found for OBSOLETE: Osteoporosis-macrocephaly-blindness-joint hyperlaxity syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: Osteoporosis-macrocephaly-blindness-joint hyperlaxity syndrome community →

No specialists are currently listed for OBSOLETE: Osteoporosis-macrocephaly-blindness-joint hyperlaxity syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Osteoporosis-macrocephaly-blindness-joint hyperlaxity syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Osteoporosis-macrocephaly-blindness-joint hyperlaxity syndromeForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Osteoporosis-macrocephaly-blindness-joint hyperlaxity syndrome.

Start the conversation →

Latest news about OBSOLETE: Osteoporosis-macrocephaly-blindness-joint hyperlaxity syndrome

No recent news articles for OBSOLETE: Osteoporosis-macrocephaly-blindness-joint hyperlaxity syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Since this diagnosis is now considered obsolete, is there a more current diagnosis that fits my symptoms?,Would whole exome or whole genome sequencing help identify the genetic cause?,What treatments are available to strengthen my bones and prevent fractures?,What can be done to preserve or support my remaining vision?,How should I manage joint hyperlaxity to prevent injuries?,Are there any clinical trials or research studies I might be eligible for?,What specialists should I be seeing regularly for ongoing care?

Common questions about OBSOLETE: Osteoporosis-macrocephaly-blindness-joint hyperlaxity syndrome

What is OBSOLETE: Osteoporosis-macrocephaly-blindness-joint hyperlaxity syndrome?

Osteoporosis-macrocephaly-blindness-joint hyperlaxity syndrome is an extremely rare condition that has been described in medical literature but is now classified as 'obsolete' in disease databases, meaning it may have been reclassified, merged with another condition, or its original description may no longer be considered a distinct syndrome. The condition was originally described as involving a combination of osteoporosis (weakened, fragile bones), macrocephaly (an unusually large head), blindness or severe vision loss, and joint hyperlaxity (overly flexible or loose joints). These features t